Obesity is a significant risk factor for breast cancer in Arab women

por Elkum, Naser, Al-Tweigeri, Taher, Ajarim, Dahish, Al-Zahrani, Ali, Amer, Suad M Bin, Aboussekhra, Abdelilah
Publicado 2014

Successful outcome of Langerhans cell histiocytosis complicated by therapy-related myelodysplasia and acute myeloid leukemia: a case report

por Al-Anazi, Khalid A, Alshehri, Abdulrahman, Al-Zahrani, Hazza A, Al-Mohareb, Fahad I, Maghfoor, Irfan, Ajarim, Dahish
Publicado 2008

Fascin Is a Key Regulator of Breast Cancer Invasion That Acts via the Modification of Metastasis-Associated Molecules

por Al-Alwan, Monther, Olabi, Safiah, Ghebeh, Hazem, Barhoush, Eman, Tulbah, Asma, Al-Tweigeri, Taher, Ajarim, Dahish, Adra, Chaker
Publicado 2011

Single-Institute Review of HER-2/Neu-Positive Invasive Lobular Breast Carcinoma in an Arab Population

por Osmani, Asif Husain, Tulbah, Asma M., Alsayed, Adher, AlShanqeeti, Ali, Al-Twegieri, Taher, Ajarim, Dahish S., Suleman, Kausar
Publicado 2021

Weekly Paclitaxel given concurrently with Durvalumab has a favorable safety profile in triple-negative metastatic breast cancer

por Ghebeh, Hazem, Al-Sayed, Adher, Eiada, Riham, Cabangon, Leilani, Ajarim, Dahish, Suleman, Kausar, Tulbah, Asma, Al-Tweigeri, Taher
Publicado 2021

Gemcitabine-Induced Myositis in a Luminal B Breast Cancer patient: A Case Report

por Badran, Ahmed, Ali, Saad Salman, Arabi, Tarek Ziad, Hinkston, Abdullaah Khaleel, Shaik, Abdullah, Elshenawy, Mahmoud A, Ajarim, Dahish
Publicado 2023

Association Between Neutrophil-Lymphocyte Ratio and Oncotype Dx Recurrence Score in Early-Stage Hormonal Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer

por Alshamsan, Bader, Alshibany, Aisha, Elshenawy, Mahmoud A, Badran, Ahmed, Elhassan, Tusneem, Ajarim, Dahish, Alsayed, Adher, Suleman, Kausar, Al-Tweigeri, Taher
Publicado 2021

Overexpression of PARP is an independent prognostic marker for poor survival in Middle Eastern breast cancer and its inhibition can be enhanced with embelin co-treatment

por Siraj, Abdul Khalid, Pratheeshkumar, Poyil, Parvathareddy, Sandeep Kumar, Divya, Sasidharan Padmaja, Al-Dayel, Fouad, Tulbah, Asma, Ajarim, Dahish, Al-Kuraya, Khawla S.
Publicado 2018

Association Between Obesity and Clinicopathological Profile of Patients with Newly Diagnosed Non-Metastatic Breast Cancer in Saudi Arabia

por Alshamsan, Bader, Suleman, Kausar, Agha, Naela, Abdelgawad, Marwa I, Alzahrani, Mashari J, Elhassan, Tusneem, Al-Tweigeri, Taher, Ajarim, Dahish, Alsayed, Adher
Publicado 2022

Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: The Saudi Arabia experience

por Elkum, Naser, Dermime, Said, Ajarim, Dahish, Al-Zahrani, Ali, Alsayed, Adher, Tulbah, Asma, Al Malik, Osama, Alshabanah, Mohamed, Ezzat, Adnan, Al-Tweigeri, Taher
Publicado 2007

High Expression of Cyclin D1 is an Independent Marker for Favorable Prognosis in Middle Eastern Breast Cancer

por Siraj, Abdul K, Parvathareddy, Sandeep Kumar, Annaiyappanaidu, Padmanaban, Ahmed, Saeeda O, Siraj, Nabil, Tulbah, Asma, Al-Dayel, Fouad, Ajarim, Dahish, Al-Kuraya, Khawla S
Publicado 2021

ALK alteration is a frequent event in aggressive breast cancers

por Siraj, Abdul K., Beg, Shaham, Jehan, Zeenath, Prabhakaran, Sarita, Ahmed, Maqbool, R.Hussain, Azhar, Al-Dayel, Fouad, Tulbah, Asma, Ajarim, Dahish, Al-Kuraya, Khawla S.
Publicado 2015

Identification of novel BRCA founder mutations in Middle Eastern breast cancer patients using capture and Sanger sequencing analysis

por Bu, Rong, Siraj, Abdul K., Al‐Obaisi, Khadija A.S., Beg, Shaham, Al Hazmi, Mohsen, Ajarim, Dahish, Tulbah, Asma, Al‐Dayel, Fouad, Al‐Kuraya, Khawla S.
Publicado 2016

FoxM1 is an independent poor prognostic marker and therapeutic target for advanced Middle Eastern breast cancer

por Siraj, Abdul Khalid, Pratheeshkumar, Poyil, Parvathareddy, Sandeep Kumar, Qadri, Zeeshan, Thangavel, Saravanan, Ahmed, Saeeda, Al-Dayel, Fouad, Tulbah, Asma, Ajarim, Dahish, Al-Kuraya, Khawla S.
Publicado 2018

Behavior and Outcomes of Pregnancy Associated Breast Cancer

por Suleman, Kausar, Osmani, Asif Husain, Hashem, Hashem Al, Twegieri, Taher Al, Ajarim, Dahish, Jastaniyah, Noha, Khayal, Wafa Al, Malik, Osama Al, Sayed, Adhar Al
Publicado 2019

PD-L1 Protein Expression in Middle Eastern Breast Cancer Predicts Favorable Outcome in Triple-Negative Breast Cancer

por Parvathareddy, Sandeep Kumar, Siraj, Abdul K., Ahmed, Saeeda O., Ghazwani, Laila Omar, Aldughaither, Saud M., Al-Dayel, Fouad, Tulbah, Asma, Ajarim, Dahish, Al-Kuraya, Khawla S.
Publicado 2021

XIAP over-expression is an independent poor prognostic marker in Middle Eastern breast cancer and can be targeted to induce efficient apoptosis

por Hussain, Azhar R., Siraj, Abdul Khalid, Ahmed, Maqbool, Bu, Rong, Pratheeshkumar, Poyil, Alrashed, Alanood M., Qadri, Zeeshan, Ajarim, Dahish, Al-Dayel, Fouad, Beg, Shaham, Al-Kuraya, Khawla S.
Publicado 2017

Impact of Pathologic Complete Response following Neoadjuvant Chemotherapy ± Trastuzumab in Locally Advanced Breast Cancer

por Al-Tweigeri, Taher, Elshenawy, Mahmoud, Badran, Ahmed, Omar, Ayman, Suleman, Kausar, Al Malik, Osama, Anwar, Ihab, Jastaniya, Noha, Tulbah, Asma, Al Shabanah, Mohammad, Ajarim, Dahish, Al Sayed, Adher
Publicado 2021

Prevalence of germline TP53 mutation among early onset middle eastern breast cancer patients

por Siraj, Abdul Khalid, Masoodi, Tariq, Bu, Rong, Parvathareddy, Sandeep Kumar, Iqbal, Kaleem, Azam, Saud, Al-Rasheed, Maha, Ajarim, Dahish, Tulbah, Asma, Al-Dayel, Fouad, Al-Kuraya, Khawla Sami
Publicado 2021

Age-Specific Gene Expression Signatures for Breast Tumors and Cross-Species Conserved Potential Cancer Progression Markers in Young Women

por Colak, Dilek, Nofal, Asmaa, AlBakheet, AlBandary, Nirmal, Maimoona, Jeprel, Hatim, Eldali, Abdelmoneim, AL-Tweigeri, Taher, Tulbah, Asma, Ajarim, Dahish, Malik, Osama Al, Inan, Mehmet S., Kaya, Namik, Park, Ben H., Bin Amer, Suad M.
Publicado 2013